Walleye Capital LLC Travere Therapeutics, Inc. Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

A detailed history of Walleye Capital LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 488,453 shares of TVTX stock, worth $9.92 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

488,453

Previous 20,700 2259.68%

Holding current value

$9.92 Million

Previous $170,000 3919.41%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.89 - $15.21 $1.75 Million - $3.38 Million	221,982 Added 83.3%	488,453 $6.83 Million
Q2 2024 Aug 14, 2024	BUY	$5.26 - $8.28 $1.34 Million - $2.1 Million	254,096 Added 2053.3%	266,471 $2.19 Million
Q1 2024 May 15, 2024	BUY	$7.18 - $9.82 $88,852 - $121,522	12,375 New	12,375 $95,000
Q3 2023 Nov 14, 2023	SELL	$7.64 - $17.25 $5.36 Million - $12.1 Million	-700,963 Reduced 95.52%	32,899 $294,000
Q2 2023 Aug 14, 2023	BUY	$15.3 - $22.61 $10.6 Million - $15.7 Million	692,631 Added 1679.88%	733,862 $11.3 Million
Q1 2023 May 15, 2023	SELL	$17.82 - $22.89 $8.3 Million - $10.7 Million	-465,852 Reduced 91.87%	41,231 $927,000
Q4 2022 Feb 14, 2023	BUY	$18.47 - $26.14 $3.12 Million - $4.41 Million	168,659 Added 49.84%	507,083 $10.7 Million
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $2.99 Million - $3.74 Million	130,529 Added 62.79%	338,424 $8.34 Million
Q2 2022 Aug 08, 2022	BUY	$20.94 - $30.01 $866,392 - $1.24 Million	41,375 Added 24.85%	207,895 $5.04 Million
Q1 2022 May 16, 2022	BUY	$23.61 - $30.6 $2.91 Million - $3.78 Million	123,425 Added 286.4%	166,520 $4.29 Million
Q4 2021 Mar 03, 2022	BUY	$24.34 - $31.17 $1.05 Million - $1.34 Million	43,095 New	43,095 $1.34 Million
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $295,658 - $570,133	-22,778 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$14.11 - $26.4 $196,566 - $367,778	13,931 Added 157.47%	22,778 $332,000
Q1 2021 May 17, 2021	BUY	$23.37 - $31.77 $206,754 - $281,069	8,847 New	8,847 $221,000

Others Institutions Holding TVTX

# of Institutions

196

Shares Held

84.9M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.3B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Travere Therapeutics, Inc. Transaction History